Mama’s Creations Stock Analysis: Buy or Sell? Valuation & Margins

Quick Thesis

• Rated Hold — fast growth is already priced in.
• Strongest strength: net debt/EBITDA is -0.7x TTM, so the balance sheet is flexible.
• Main risk: gross margin is only 24.5% TTM, leaving little cushion if pricing pressure rises.
• Valuation is rich at 3.5x EV/revenue and 43.7x EV/EBITDA.
• I would move higher if EBITDA margin reaches the low double digits and stays there.

Executive Summary

Rating: HOLD | MAMA

I would put my rating as a Hold because MAMA has delivered 49.7% TTM revenue growth, but the stock already discounts that progress at 3.5x EV/revenue, 54.8x forward P/E, and a 0.7% FCF yield TTM. In my view, the key tension is that the business is scaling faster than peers, yet cash conversion is still too thin to justify a more aggressive rating. I would become more constructive if revenue growth stays above 40% for the next two quarters and EBITDA margin moves into the low double digits, because that would show the current 8.0% TTM margin is not the ceiling.

Company Profile

Mama’s Creations, Inc. is a marketer and manufacturer of fresh deli prepared foods sold in more than 12,000 grocery, mass, club, and convenience stores across the United States. It earns revenue from refrigerated meatballs, meat loaf, sausage items, pasta and rice entrées, salads, olives, and premium ready-to-heat meals, with most products sold through deli cases, hot bars, salad bars, and prepared-food sections. The company traces its roots to 2010, became MamaMancini’s Holdings, Inc. in 2013 when its common stock began trading under MMMB, and adopted the Mama’s Creations name in 2023 when the ticker changed to MAMA. It expanded through the 2021 acquisitions of T&L Creative Salads and Olive Branch for $14M, the 2022 to 2023 acquisition of Chef Inspirational Foods for $37M, and the 2025 Crown 1 Foods asset purchase for about $17.3M. Listed on Nasdaq under MAMA, it operates with 581 full-time employees and 1 part-time employee.

Economic Moat

Business Model

The strongest structural advantage is the company’s ability to sell a broad line of fresh deli prepared foods through a national retail network that now reaches over 12,000 stores, while keeping most production in-house and using SQF- and USDA-certified facilities. In my view, that is hard for a well-funded competitor to copy within 3 years because it combines shelf access, food safety certification, and vertically integrated manufacturing rather than relying on a single brand claim. The 50-year exclusive license, with a 25-year extension option, to use Dan Dougherty’s grandmother’s recipes also helps anchor the core meatball franchise, but I see that as supportive rather than the main moat.

The business has clearly broadened over time. In 2025’s 10-K, the company was found in over 10,000 stores nationally; today that figure is over 12,000, which means distribution has expanded enough to make the platform more relevant to national buyers and to reduce dependence on a few regional placements. In 2021, the company added T&L Creative Salads and Olive Branch, both New York-based prepared-food businesses, and in 2022 to 2023 it moved from a minority stake in Chef Inspirational Foods, LLC to full ownership, which widened the product set beyond the original Italian core. On September 2, 2025, Crown 1 Foods, Inc. acquired substantially all of the assets of Crown I Enterprises, Inc., a full-service food manufacturer focused on value-added proteins and premium ready-to-heat meals, and that acquisition pushed the model further toward a one-stop deli solutions platform. The result is a business that is structurally stronger than 5 years ago because it has more categories, more manufacturing control, and more customer touchpoints, even though customer concentration and retailer bargaining power still limit how far that strength can be monetized.

Business & Operating Risks

The biggest disclosed risk is customer concentration: in the year ended January 31, 2026, two customers represented approximately 38% and 17% of gross sales, and two customers represented approximately 35% and 12% of total gross outstanding receivables as of January 31, 2026, according to the risk factors in their SEC 10-K. That means a single lost account could cut revenue and receivables at the same time, so the stock is exposed to abrupt order swings rather than a smooth consumer demand base. The financial data in this article already shows the risk is materializing, because Q1 2026 revenue fell 5.2% year over year while the company still depended on a narrow customer set. Retailer bargaining power is the next pressure point: the filing says consolidation, large-format retailers, and e-commerce platforms give major grocery chains, discounters, and online marketplaces leverage to demand lower prices, higher promotional allowances, and less favorable shelf space. That is consistent with the article’s gross margin pressure and means margin recovery depends on customer negotiations, not just volume growth.

Food safety, recall, and product liability risk is also central. The company discloses that products can be recalled for labeling, contamination, damage, or tampering, and that a widespread recall could trigger inventory destruction, liability claims, lost sales, and adverse publicity. Because the business sells food for human consumption, even a single contamination event could force a withdrawal and damage distributor confidence, so this is not a theoretical legal risk. Supply chain and raw material inflation are another live issue: the filing names tomatoes, onions, poultry, meats, spices, flour, packaging materials, water, fuel, and energy, and says cost increases or restrictions in availability could hurt results if prices cannot be raised enough to offset them. That risk is already showing up in the margin profile, so the filing’s “could” language has partly become a current earnings problem. In my view, these risks pressure the moat at the margin rather than breaking it outright; the real threat is to pricing power and customer retention, not to the company’s ability to manufacture and distribute the product set.

Management Discussion & Analysis

Management is actively responding to the concentration and margin risks, but the response is still more visible in growth than in profitability. The Crown 1 Foods acquisition, a full-service manufacturer of value-added proteins and ready-to-heat meals, is the main capital allocation move for FY2026, and the $17.3M cash purchase was funded alongside a private placement that raised approximately $18.9M in net proceeds. That tells me management is using equity capital to buy capacity and broaden the product set rather than to de-lever, which is constructive only if the acquired assets lift throughput and customer access faster than dilution and integration costs. The same filing says the proceeds were used for acquisition expenses and debt repayments, while the company also added approximately $5.4M outstanding under the Term Loan Agreement due October 1, 2030, so the balance sheet is still being actively financed rather than cleaned up. Management is also leaning on price increases, competitive sourcing, and manufacturing and overhead cost control to offset higher fuel, freight, and labor costs, but the numbers only partly support that narrative because gross profit margin stayed flat at 25% in FY2026 even as operating expenses rose 40.0% to 35.9M. The growth message is real, with net sales up 39.0% in FY2026 and about $23.2M of that coming from Crown 1, but the margin outcome says investors should view the acquisition as a scale step, not proof yet that the model is becoming more profitable.

In FY2025, management said revenue growth was being offset by manufacturing inefficiencies tied to the Farmingdale, New York facility upgrade and higher commodity costs, and FY2026 did show better sales and earnings, with net income rising to $5.3M from $3.7M in FY2025. That said, the earlier promise that procurement efficiencies and stronger buying power would improve gross margin did not translate into margin expansion in FY2026, because gross profit margin remained at 25% in both FY2025 and FY2026. The leadership team has also changed over the period, as the current filing refers to new executive hires and performance-related compensation increases, but it does not clearly lay out a CEO or CFO transition in the MD&A text provided, so I cannot credit a clean management handoff from this record alone. The tone has generally been optimistic across the last several filings, with repeated emphasis on growth, efficiencies, and a one-stop-shop deli platform, yet the financial path has been uneven enough that I would call the execution record mixed rather than fully dependable. Management’s current MD&A is a mild bull signal for the thesis because the 39.0% FY2026 sales growth and 24.3M of working capital show expansion capacity, but the flat 25% gross margin and heavier financing use keep that signal from being strongly positive.

Recent Events

The most significant development I see here is the board expansion on April 2, 2026, when Mama’s Creations added Fred Halvin as a sixth director effective May 1, 2026. That strengthens governance capacity at a time when the company is still scaling, and it suggests the board is preparing for a more complex operating profile rather than standing still.

The other two 8-Ks, filed on April 14, 2026 and June 8, 2026, were routine earnings releases for the fourth quarter ended January 31, 2026 and the first quarter ended April 30, 2026. They do not add a new strategic catalyst, but they do confirm management is keeping the market updated on execution cadence. In my view, the recent disclosures modestly strengthen the investment case because the only material non-routine event was a governance addition, while the rest of the filings were standard quarterly reporting.

Financial Analysis

Growth

MAMA — Financial Growth (Quarterly, USD Mil)

Source: Yahoo Finance — Quarterly Financial Statements

Revenue accelerated from 35.3M in Q1 2025 to 54M in Q1 2026, after 35.2M in Q2 2025 and 47.3M in Q3 2025, so the top line moved from flat to clearly higher over the last four reported quarters. EBITDA grew faster than revenue in Q1 2026, rising to $4.79M from $2.83M in Q1 2025, which tells me the business is finally getting some operating leverage as scale builds. Growth is a bull signal, but it still needs to prove that the higher sales base can carry better cash generation.

Profitability

MAMA — Profitability (TTM)

Source: Yahoo Finance — Trailing Twelve Months (TTM)

TTM operating margin was 5.1%, net margin was 3.2%, gross margin was 24.5%, and EBITDA margin was 8.0%. The spread from 24.5% gross margin to 5.1% operating margin shows a heavy opex load, so the core issue is scale and overhead absorption rather than weak product economics. EBITDA margin above operating margin by 2.9 points suggests depreciation and amortisation are not the main drag; the bigger pressure sits in selling, general and administrative costs and plant overhead. TTM return on assets was 8.5% and TTM return on equity was 14.9%, so equity returns are being amplified by a modest capital structure rather than by exceptional asset productivity alone. The gap between ROE and ROA is not extreme, which means leverage is helping but not distorting the picture. The company is profitable, but the margin stack still looks early-stage and execution-sensitive. Investors should watch for operating margin moving into the high single digits, because that would show fixed costs are being spread over a larger base. This is a neutral-to-bullish profitability signal because margins are positive and returns are respectable, but the gap to stronger operating leverage remains visible.

Valuation

MAMA — Valuation Multiples

Source: Yahoo Finance

MAMA’s primary valuation anchor is EV/revenue at 3.5x, because trailing earnings are still too thin to make P/E a clean read and the market is effectively paying for a fresh-food platform that can convert a 658.5M enterprise value into higher sales density and better cash conversion. Price/sales (TTM) is 4.0x, which says the equity is not cheap on a revenue basis either, especially with only a 0.7% FCF yield on a TTM basis. Trailing P/E is 109.6x and forward P/E is 54.8x, so the stock is pricing in a sharp step-up in earnings power rather than the current 0.3 forward EPS. EV/EBITDA is 43.7x, which is rich for a food manufacturer and implies the market is assuming EBITDA can scale materially from the current low base. Price/book is 12.1x, while book value per share is just 1.4, so the market is paying well above accounting equity for growth and acquisition optionality. Beta is 0.6, which helps the risk profile but does not make the multiple cheap. FCF yield is 0.7%, so the valuation picture is a bear signal.

On my read, fair value sits in a range of 3.8-$16.9 per share using a simple peer EV/revenue frame, but the stock already trades near the upper half of that band once you adjust for its net cash position and current share count. The analyst target range of 20–25 sits above that estimate, and with 7 opinions behind it, that is a real consensus rather than a token one. I read that gap as the market and analysts giving MAMA credit for faster earnings conversion than the current cash flow profile supports. Forward EPS of 0.3 also looks light versus peers such as SFM at $6, MZTI at $7.2, and CPB at $1.9, so the stock is expensive on a like-for-like earnings basis even before you adjust for its smaller scale.

Leverage

MAMA — Leverage & Coverage (Quarterly)

Source: Yahoo Finance — Quarterly Financial Statements

Total debt was 13.7M (mrq), and total debt to equity was 24.7% (mrq), which is modest for a food manufacturer and leaves the capital structure flexible. The current ratio was 2.3x, so near-term liquidity looks comfortable rather than tight. Cash generation was positive but not large: operating cash flow was $10.43M (TTM) and levered free cash flow was $5.228M (TTM), with an FCF margin of 2.8% (TTM). Net debt to EBITDA was -0.7x (TTM), which means cash exceeds debt and gives the company room to absorb a downturn or fund small acquisitions without immediate refinancing pressure. The main watch item is not solvency but cash conversion, because EBITDA margin was 8.0% (TTM) while free cash flow stayed only $5.228M (TTM), so working capital, capex, or interest are taking a meaningful share of earnings. In my opinion, this is a low refinancing risk balance sheet. The leverage profile supports the thesis, but it does not solve the valuation problem because the market is still paying for growth, not for balance-sheet repair.

Insider Activity

The insider transaction record I see here is one-sided: 2 open-market sales and 0 open-market purchases in the 2025-04-15 to 2026-04-17 window, with total open-market selling of $248,223. The activity is concentrated in a single insider, Adam Laurance Michaels, so the signal is narrow rather than broad, but it still points to limited near-term alignment from open-market buying. Bear signal.

Comparable Analysis

Growth

Source: Yahoo Finance

MAMA’s revenue grew 49.7% TTM and quarterly earnings grew 66.7% year over year, far ahead of AMNF at 8.5% revenue growth, SFM at 4.7%, MZTI at -1.0%, CPB at -4.4%, and BGS at -9.7%. That premium is only useful if it persists, because MAMA’s 189.2M TTM revenue base is still small and the market is already paying for a much larger earnings stream than the current 0.1 diluted EPS TTM shows.

Valuation

Source: Yahoo Finance

MAMA trades at 3.5x EV/revenue, 4.0x price/sales, 109.6x trailing P/E, 54.8x forward P/E, and only a 0.7% FCF yield TTM, versus AMNF at 4.3x EV/revenue but 2.7% FCF yield, SFM at 1.0x EV/revenue and 5.3% FCF yield, MZTI at 1.5x and 6.1%, CPB at 1.4x and 8.5%, and BGS at 1.3x and 62.1%. On a simple peer EV/revenue range of 1.0x to 4.3x applied to MAMA’s 189.2M revenue, implied EV is $198.7M to $811.5M, or about $3.8 to $16.9 per share after netting $24.4M cash and $13.7M debt across 46.5M shares; that range brackets the stock, but the low FCF yield says the market is paying for execution that still needs to show up in cash.

Profitability

Source: Yahoo Finance

MAMA’s 24.5% gross margin, 8.0% EBITDA margin, 5.1% operating margin, and 3.2% net margin all trail AMNF’s 48.7%, 34.3%, 29.5%, and 24.8%, and also sit below SFM’s 38.9%, 9.4%, 7.5%, and 5.6%. The gap looks more like scale and cost structure than a broken model, because MAMA’s gross margin is not far from BGS at 22.1% and CPB at 29.2%, but its operating margin is still thin, which means overhead absorption remains the main constraint.

Leverage

Source: Yahoo Finance

MAMA’s debt/equity is 24.7%, net debt/EBITDA is -0.7x, current ratio is 2.3x, and FCF margin is 2.8%, versus CPB at 182.0%, 4.1x, 0.9x, and 6.1%, and BGS at 651.8%, 7.7x, 1.6x, and 9.9%. AMNF is similarly cash-rich at -0.6x net debt/EBITDA and 12.2% FCF margin, so MAMA’s balance sheet is good, but not uniquely so; the investor takeaway is that leverage is not the reason for the stock’s premium.

Conclusion

I would put my rating as a Hold because MAMA has delivered 49.7% revenue growth over the last twelve months, but the market is already paying 109.6x trailing P/E for only 0.1 of TTM diluted EPS and a 0.7% free cash flow yield, meaning the stock is priced for much better cash conversion than it has delivered. The strongest support is the balance sheet, with net debt at -0.7x EBITDA TTM and a 2.3x current ratio mrq, so I do not see financing stress. The main risk is execution: gross margin was only 24.5% TTM and operating margin was 5.1% TTM, which leaves little room if retailer pricing pressure or integration costs rise. I would turn more constructive if operating margin moves into the high single digits, because that would show the sales growth is finally converting into durable earnings.

The bull case is straightforward: if revenue growth stays above 40% for the next two quarters and EBITDA margin moves into the low double digits, the current 8.0% TTM margin would no longer look like a ceiling. On the latest revenue base of 52.8M in Q1 2026, a move from 8.0% to 12.0% EBITDA margin would add roughly $2.1M of quarterly EBITDA, which would show that overhead is being absorbed faster than sales are growing and would make the current valuation easier to defend. The bear case is just as clear: if revenue growth falls below 20% year over year for two straight quarters or gross margin slips under 23%, the premium multiple would be resting on a fading growth rate rather than a durable operating model. I would also watch the insider tape, because continued open-market selling without offsetting purchases would be a poor look for a stock already trading at 54.8x forward P/E.

Weighing both paths, I lean to Hold because the growth rate is still fast enough to keep the rerating case alive, but not yet strong enough to justify chasing the stock after a 94.8% 52-week gain. The key question is whether the next two quarters show higher EBITDA and better free cash flow, or whether the current margin profile proves to be the limit.

What to Watch Next

• Revenue growth above 40% for two more quarters — would support a move toward Buy.
• EBITDA margin in the low double digits — would show overhead absorption is improving.
• Gross margin below 23% — would argue the premium multiple is getting harder to defend.
• Operating margin in the high single digits — would confirm the sales growth is turning into earnings.
• Continued open-market insider selling — would weaken alignment at a rich valuation.

What’s your take? I rated Mama’s Creations (MAMA) HOLD above — but the goal here is to get this right, not just to publish an opinion. What would you add to this analysis, or which risk or catalyst do you think I’m under- or over-weighting? Tell me in the comments.

Sources

• SEC 10-K Annual Report — filed 2026-04-14
• SEC 8-K Filing (2026-06-08)
• SEC 8-K Filing (2026-04-14)
• SEC 8-K Filing (2026-04-02)
• SEC Form 4 Insider Transaction (2026-04-21)
• SEC Form 4 Insider Transaction (2026-04-21)
• SEC Form 4 Insider Transaction (2026-04-20)
• SEC 10-K Annual Report — FY2026
• SEC 10-K Annual Report — FY2025
• SEC 10-K Annual Report — FY2024
• SEC 10-K Annual Report — FY2023
• SEC 10-K Annual Report — FY2022

Data sourced from Yahoo Finance and SEC EDGAR. Not investment advice.